Moreover, first functional evaluation proofed that blockade of TIGIT and/or PVRIG prevented NK cell exhaustion and promotes NK cell–dependent tumor immunity in solid and hematological tumor models [24, 63]. This evidence concerns the gene PVRIG and neoplasm.